seed
Stage
1
Investors
About
Apoglyx is a biotech company developing innovative solutions for the treatment of metabolic diseases. Their lead program focuses on a novel therapeutic approach for Type 2 Diabetes.
Explore Apoglyx's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.